Institutional investors purchased a net $146.9 thousand shares of ICPT during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 54.38% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 4.0 Thousand shares of Intercept Pharmaceuticals...
SIVIK GLOBAL HEALTHCARE LLC Bought 2.0 Thousand shares of Intercept Pharmaceuticals...